Use of dopamine receptor antagonists in palliative tumor therapy
    7.
    发明授权
    Use of dopamine receptor antagonists in palliative tumor therapy 失效
    多巴胺受体拮抗剂在姑息性肿瘤治疗中的应用

    公开(公告)号:US06696428B2

    公开(公告)日:2004-02-24

    申请号:US10210881

    申请日:2002-08-02

    IPC分类号: A61K31685

    摘要: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.

    摘要翻译: 某些乙酰胆碱受体拮抗剂如多潘立酮和匹莫齐特可以拮抗由诸如米替芬等烷基磷酰胆碱引起的体重下降的副作用。 烷基磷酸加上拮抗剂的组合对烷基磷酸胆碱的抗肿瘤作用没有任何影响。 该组合也不会在动物中产生新的副作用。